US 7244741
Fredericamycin derivatives as medicaments for treating tumours
granted A61PA61P17/00A61P29/00
Quick answer
US patent 7244741 (Fredericamycin derivatives as medicaments for treating tumours) held by Biofrontera Discovery GmbH expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biofrontera Discovery GmbH
- Grant date
- Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P17/00, A61P29/00, A61P33/00, A61P35/00